Rapid Infusion of a Loading Dose of Intravenous Levetiracetam With Minimal Dilution: A Safety Study

Abstract

Intravenous antiepileptic drugs are required in patients needing urgent treatment or unable to take oral medication. The safety of intravenous levetiracetam has been established in prospective studies of adult epilepsy and healthy participants. The authors performed a prospective, single-center study to evaluate the safety of a rapid loading dose of intravenous levetiracetam. Patients were divided into 3 equal dosing groups (N = 15 each): 20, 40, and 60 mg/kg (corresponding to maximum doses of 1, 2, and 3 g). Electrocardiogram and safety assessment were performed during the infusion. Ages were 4 to 32 years. Postinfusion serum levetiracetam concentrations were 14 to 189 μg/mL. There were no significant changes in blood pressure, no local infusion site reactions, and no electrocardiogram abnormalities. The authors concluded that high serum levels of parenteral levetiracetam can be achieved rapidly and safely, in a small infusion volume. This finding has important implications for the treatment of status epilepticus.

Keywords

antiepileptic drugs epilepsy partial seizures open-label trials levetiracetam intravenous

Get full access to this article

View all access options for this article.

References

Pellock JM , Glauser TA , Bebin EM , et al. Pharmacokinetic study of levetiracetam in children. Epilepsia. 2001;42:1574-1579.

Ramael S. , Daoust A. , Otoul C. , et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006;47:1128-1135.

Baulac M. , Brodie MJ , Elger CE , et al. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia . 2007;48:589-592.

Goraya JS , Khurana DS , Valencia I. , et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol. 2008;38:177-180.

Michaelides C. , Thibert RL , Shapiro MJ , et al. Tolerability and dosing experience of intravenous levetiracetam in children and infants . Epilepsy Res. 2008;81:143-147.

Grosso S. , Cordelli DM , Franzoni E. , et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure. 2007;16:345-350.

Rowland M. , Tozer TN Intravenous Dose. Clinical Pharmacokinetics Concepts and Applications . 3rd ed. Baltimore, MD: Wilkins & Wilkins; 1995.

Fosphenytoin Sodium Injection. Cerebyx® Prescribing Information. New York, NY: Pfizer, Inc.

Wheless JW , Venkataraman V. Safety of high intravenous valproate loading doses in epilepsy patients . J Epilepsy. 1998;11:319-324.

10.

Wheless JW , Vazquez BR , Kanner AM , Ramsay RE , Morton L. , Pellock JM Rapid infusion with valproate sodium is well tolerated in patients with epilepsy . Neurology. 2004;63:1507-1508.

11.

Morton LD , O'Hara KA , Coots BP , Pellock JM Safety of rapid intravenous valproate infusion in pediatric patients . Pediatr Neurol. 2007;36:81-83.

12.

Venkataraman V. , Wheless JW Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res. 1999;35:147-153.

13.

Limdi NA , Knowlton RK , Cofield SS , et al. Safety of rapid intravenous loading of valproate. Epilepsia. 2007;48:478-483.

14.

Valproate Sodium Injection. DEPACON® Prescribing Information. Chicago, IL:Abbott Laboratories.

15.

Ramael S. , Smedt F. , Toublanc N. , et al. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects . Clin Ther. 2006;28: 734-744.